Synthetic Blood International, Inc. (SYBD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Synthetic Blood International, Inc. (SYBD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: taylorfife who wrote (63)	5/24/1999 10:35:00 AM
From: Micro-Selector	Read Replies (1) of 91

IMO, this is great news! It shows SYBD is right on track. This new stock will be used to help secure future financing for product development and clinical trials. "Private and institutional investors have expressed interest in financing further development of our products up to the corporate partner stage," said Robert Nicora, SYBD president. "The ability to issue preferred, convertible stock will aid in securing this financing without diluting existing common stock." Approval to issue preferred stock does not affect plans for a current, private placement which is expected to result in an announcement soon. Rather, it will be used to secure additional funding in the future.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next